INHIBITORS OF ANF METABOLISM - POTENTIAL THERAPEUTIC AGENTS IN CARDIOVASCULAR-DISEASE

被引:15
|
作者
GRANGER, JP
机构
[1] Department of Physiology, Eastern Virginia Medical School, Norfolk, VA
[2] Department of Physiology, Eastern Virginia Medical School, Norfolk, VA 23501
关键词
D O I
10.1161/01.CIR.82.1.313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:313 / 315
页数:3
相关论文
共 50 条
  • [2] LIPOPROTEIN METABOLISM AND CARDIOVASCULAR-DISEASE
    PACKARD, CJ
    SHEPHERD, J
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1987, 15 (03) : 341 - 343
  • [3] Flavonoids: Potential therapeutic agents for cardiovascular disease
    Liu, Yingxue
    Luo, Jing
    Peng, Lin
    Zhang, Qi
    Rong, Xi
    Luo, Yuhao
    Li, Jiafu
    HELIYON, 2024, 10 (12)
  • [4] The potential of adipokines as therapeutic agents for cardiovascular disease
    Shibata, Rei
    Ohashi, Koji
    Murohara, Toyoaki
    Ouchi, Noriyuki
    CYTOKINE & GROWTH FACTOR REVIEWS, 2014, 25 (04) : 483 - 487
  • [5] ASPIRIN AS A THERAPEUTIC AGENT IN CARDIOVASCULAR-DISEASE
    FUSTER, V
    DYKEN, ML
    VOKONAS, PS
    HENNEKENS, C
    CIRCULATION, 1993, 87 (02) : 659 - 675
  • [6] CARBOHYDRATE-METABOLISM IN CARDIOVASCULAR-DISEASE
    OPIE, LH
    STUBBS, WA
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1976, 5 (03): : 703 - 729
  • [7] MOLECULAR-WEIGHT HETEROGENEITY OF PLASMA-ANF IN CARDIOVASCULAR-DISEASE
    ARENDT, RM
    GERBES, AL
    RITTER, D
    STANGL, E
    KLINISCHE WOCHENSCHRIFT, 1986, 64 : 97 - 102
  • [8] CILAZAPRIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN CARDIOVASCULAR-DISEASE
    DEGET, F
    BROGDEN, RN
    DRUGS, 1991, 41 (05) : 799 - 820
  • [9] TOXIC AGENTS, CARDIOVASCULAR-DISEASE, AND POLLUTED HOME
    BURCH, GE
    AMERICAN HEART JOURNAL, 1974, 87 (06) : 679 - 680
  • [10] CARDIOVASCULAR-DISEASE - CARDIOVASCULAR-DISEASE IN OKINAWA
    BONITA, R
    LANCET, 1993, 341 (8854): : 1185 - 1185